PATENT CLAIM ANALYSIS

Application Number: 16152008
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["544", "366000"]

Abstract:
Provided herein are Itraconazole analogs. Also provided herein are methods of inhibition of Hedgehog pathway, vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, angiogenesis and treatment of disease with Itraconazole analogs.

Claim (Index 2):
The compound of  claim 1 , selected from: Compund Structure Number 201   202   203   204   205   206   207   208   209   210   211   212   213   214   215   216   217   218   219   220   221   222   223   224   225   226   227   228   229   230   231   232   233   234   235   236   237   238   239   240   241   242   243   244   245   246   247   248   249   250   251   252   253   254   255   256   257   258   259   260   261   262   263   264   265   266   267   268   269   270   271   272   273   274   275   276   277   278   279   280   281   282   283   284   285   286   287   288   289   290   291   292   293   294   295   296   297   298

Metadata:
- Claim Count in Document: 3.0
- Percentile: 97.0
- Lexical Diversity: 1.27586
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14343040', '15225021', '15481542', '14156314', '14753537']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7788563035425844
- 35 USC 102 Novelty (BERT): 0.5399369489379876
- Combined Prediction Score: 0.7549643680821247
- Mean Citation Score: 330.6821940000001
- Max Citation Score: 383.66406
- Similarity Product: 174.36544372563245

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test